0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query gbi research global rheumatic disorders drugs market 2024 increased uptake il inhibitors jak.Your search for "" gave back 1533062 results.
Tyrosine Protein Kinase JAK1 - Pipeline Review, H1 2020 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) pipeline Target...
Catalog:
Global Markets Direct
January 2020
Price: USD 3,500.00
Tyrosine Protein Kinase JAK1 - Pipeline Review, H2 2020 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - JAK1 is a...
Catalog:
Global Markets Direct
July 2020
Price: USD 3,500.00
The global Jakinibs market size was valued at US$ 14290 million in 2023. With growing demand in downstream market, the Jakinibs is forecast to a...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Oral JAK1 Inhibitor market size is projected to grow from US$ 7979.6 million in 2022 to US$ 13480 million in 2029; it is expected to grow...
Catalog:
LPI
July 2023
Price: USD 3,660.00
An oral JAK1 inhibitor is a type of medication that belongs to a class of drugs called Janus kinase (JAK) inhibitors. JAK inhibitors work by...
Catalog:
MRRPB5
August 2023
Price: USD 2,900.00
The global Rheumatic Disorders Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of %...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
The global Oral JAK1 Inhibitor market size is expected to reach $ 13630 million by 2029, rising at a market growth of 7.2% CAGR during the forecast...
Catalog:
GIR
August 2023
Price: USD 4,480.00
Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA...
Catalog:
Global Markets Direct
March 2022
Price: USD 3,500.00
Jakinibs are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Janus Kinase (JAK) inhibitors are small molecules that can be administrated orally. In addition, they are trouble free in reaching the inside of...
Catalog:
9Dimen Research
April 2021
Price: USD 3,200.00
The global Oral JAK1 Inhibitor market size was valued at USD 8393.1 million in 2022 and is forecast to a readjusted size of USD 13630 million by 2029...
Catalog:
GIR
August 2023
Price: USD 3,480.00
The global Tyrosine Kinase JAK Inhibitors market size was valued at USD 31360 million in 2023 and is forecast to a readjusted size of USD 497670...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H2 2018 Summary According to the recently published report...
Catalog:
Global Markets Direct
November 2018
Price: USD 3,500.00
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Tyrosine Kinase JAK Inhibitors market size was valued at US$ 29820 million in 2023. With growing demand in downstream market, the Tyrosine...
Catalog:
LPI
January 2024
Price: USD 3,660.00
